- Revenue 2024
- $37,190,710
- Expenses 2024
- $27,180,092
Program services were 80.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
As filed
- Subsection
- 03
- NTEE code
- P112
- Classification
- 1000
- Street
- 504 RXR PLZ
These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).
Mission and programs · 2024
Mission
THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD. SEE SCHEDULE O.THE LUSTGARTEN FOUNDATION IS BOLDLY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FOCUSES ON TRANSLATING OUR UNDERSTANDING OF THE UNDERLYING BIOLOGY OF PANCREATIC CANCER INTO CLINICAL APPLICATIONS TO CHANGE, EXTEND, AND ULTIMATELY SAVE PATIENTS' LIVES. IN FY25, THE FOUNDATION AWARDED $18 MILLION TO FUEL CUTTING-EDGE PANCREATIC CANCER RESEARCH, INCLUDING 10 NEW GRANTS TO RESEARCHERS AT SEVEN LEADING INSTITUTIONS. RESEARCH EFFORTS ARE CONCENTRATED ON THREE KEY PILLARS: EARLY DETECTION AND INTERCEPTION, DRUG DEVELOPMENT, AND PERSONALIZED MEDICINE.
Activities or mission (Part I)
THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD.THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD, FUNDING PREEMINENT PANCREATIC CANCER RESEARCHERS, DRIVING THE PURSUIT OF BOLD AND INNOVATIVE SCIENCE TOWARD EARLIER DETECTION AND BETTER TREATMENTS TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FUNDS RESEARCH WHERE CREATIVE RISKS YIELD HIGH REWARDS TO ACCELERATE AND EXPAND LIFE-SAVING TREATMENT OPTIONS. WE BELIEVE TIME IS EVERYTHING TO PATIENTS AND THEIR FAMILIES, AND THAT COMMUNITY IS POWER. LUSTGARTEN PROGRAMS AND EVENTS PROVIDE PEOPLE AFFECTED BY PANCREATIC CANCER A VOICE AND A PLACE TO CREATE HOPE, TOGETHER. THROUGH FY25, THE LUSTGARTEN FOUNDATION HAS INVESTED $301 MILLION IN PANCREATIC CANCER RESEARCH.
-
RESEARCH PROGRAM: THE LUSTGARTEN FOUNDATION'S MISSION IS TO ADVANCE THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. 2025 MARKED THE FOUNDATION'S 27TH YEAR OF DRIVING PIONEERING PANCREATIC CANCER RESEARCH BREAKTHROUGHS, ACCELERATING PROGRESS FASTER THAN EVER BEFORE AND PROVIDING A MORE HOPEFUL FUTURE FOR ALL PATIENTS. SEE SCHEDULE O.
Expenses $19,810,727 · Grants $18,049,864
-
PUBLIC EDUCATION AND INFORMATION PROGRAM: THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD, FUNDING PREEMINENT PANCREATIC CANCER RESEARCHERS, DRIVING THE PURSUIT OF BOLD AND INNOVATIVE SCIENCE TOWARD EARLIER DETECTION AND BETTER TREATMENTS, AND TRANSFORMING PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FUNDS RESEARCH WHERE CREATIVE RISKS YIELD HIGH REWARDS TO ACCELERATE AND EXPAND LIFE-SAVING TREATMENT OPTIONS. WE BELIEVE TIME IS EVERYTHING TO PATIENTS AND THEIR FAMILIES, AND THAT COMMUNITY IS POWER. LUSTGARTEN PROGRAMS AND EVENTS PROVIDE PEOPLE AFFECTED BY PANCREATIC CANCER A VOICE AND A PLACE TO CREATE HOPE, TOGETHER. SEE SCHEDULE O.
Expenses $1,235,976
-
PROFESSIONAL EDUCATION PROGRAM: PROFESSIONAL EDUCATION FOCUSED ON THE FOUNDATION'S SCIENTIFIC LEADERSHIP CONDUCTING HIGH-LEVEL MEETINGS WITH FUNDED SCIENTISTS AND DIRECTORS OF THE LABS PROGRAM SITES AND COLLABORATING ORGANIZATIONS. ADDITIONALLY, THE LUSTGARTEN FOUNDATION PROVIDED SUPPORT FOR THE AACR SPECIAL CONFERENCE IN PANCREAS CANCER RESEARCH, AACR-LUSTGARTEN FOUNDATION-MARK FOUNDATION JOINT WORKSHOP ON SOLVING THE EARLY STAGE DIAGNOSIS FOR RALCITRANT CANCERS, THE GORDON RESEARCH CONFERENCE ON PANCREATIC DISEASES, THE INTERNATIONAL WOMEN'S DAY SYMPOSIUM AT THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE, AND THE FOUNDATION'S SCIENTIFIC ADVISORY BOARD ANNUAL MEETING. SEE SCHEDULE O.
Expenses $773,834
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Officers and directors · 2024
As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.
-
ANDREW LUSTGARTEN
CHAIRMAN
- Total calculated
- $0
- Hours/week
- 2
-
ROBERT F VIZZA
CHAIRMAN EMERITUS
- Total calculated
- $0
- Hours/week
- 2
-
JENNIE FORTUNOFF
SECRETARY
- Total calculated
- $0
- Hours/week
- 2
-
PHILIP D'AMBROSIO
TREASURER
- Total calculated
- $0
- Hours/week
- 2
-
ADAM SILVER
VICE CHAIRMAN
- Total calculated
- $0
- Hours/week
- 2
-
SOMMER BAZURO PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
JOHN H COBB
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
JESSICA LUSTGARTEN COURTEMANCHE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
MARCIA LUSTGARTEN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
SHEILA MAHONY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
CHARLES R SCHUELER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
WILLA SHALIT
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
SCOTT PENBERTHY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
SELWYN VICKERS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
AARON KANTOFF
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
RICHARD R BARAKAT MD MBA
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
LINDA TANTAWI
CEO
- Total calculated
- $528,783
- From this org
- $489,273
- From related orgs
- $0
- Other
- $39,510
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $341,148
- Bonus
- $143,750
- Other
- $4,375
- Deferred
- $13,625
- Nontaxable benefits
- $25,885
- Filer's total
- $528,783
-
KERRI KAPLAN
PRESIDENT
- Total calculated
- $382,905
- From this org
- $341,967
- From related orgs
- $0
- Other
- $40,938
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $265,969
- Bonus
- $75,998
- Other
- $0
- Deferred
- $4,071
- Nontaxable benefits
- $36,867
- Filer's total
- $382,905
-
FAISAL JAWAID
CFO
- Total calculated
- $328,282
- From this org
- $287,237
- From related orgs
- $0
- Other
- $41,045
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $221,087
- Bonus
- $66,150
- Other
- $0
- Deferred
- $5,740
- Nontaxable benefits
- $35,305
- Filer's total
- $328,282
-
ANDREW RAKEMAN
VP RESEARCH
- Total calculated
- $314,193
- From this org
- $272,473
- From related orgs
- $0
- Other
- $41,720
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $227,323
- Bonus
- $45,150
- Other
- $0
- Deferred
- $7,266
- Nontaxable benefits
- $34,454
- Filer's total
- $314,193
-
GLEN PECK
SVP TECHNOLOGY & BUSINESS INTELLIGENCE
- Total calculated
- $307,903
- From this org
- $268,413
- From related orgs
- $0
- Other
- $39,490
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $223,013
- Bonus
- $45,400
- Other
- $0
- Deferred
- $6,024
- Nontaxable benefits
- $33,466
- Filer's total
- $307,903
-
JACLYN P LYMAN
HEAD CLINICAL RESEARCH & DEVELOPMENT
- Total calculated
- $280,150
- From this org
- $258,870
- From related orgs
- $0
- Other
- $21,280
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $224,370
- Bonus
- $34,500
- Other
- $0
- Deferred
- $5,418
- Nontaxable benefits
- $15,862
- Filer's total
- $280,150
-
STEPHANIE DERGARABEDIAN
NATIONAL DIRECTOR OF DEVELOPMENT
- Total calculated
- $214,801
- From this org
- $179,133
- From related orgs
- $0
- Other
- $35,668
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $155,883
- Bonus
- $23,250
- Other
- $0
- Deferred
- $3,958
- Nontaxable benefits
- $31,710
- Filer's total
- $214,801
-
SUSAN M JACOBSON
DIRECTOR EXTERNAL & COMMUNITY RELATIONS
- Total calculated
- $186,210
- From this org
- $166,081
- From related orgs
- $0
- Other
- $20,129
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $148,441
- Bonus
- $17,640
- Other
- $0
- Deferred
- $3,826
- Nontaxable benefits
- $16,303
- Filer's total
- $186,210
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.
Filings
-
2024
- Revenue
- $37,190,710
- Expenses
- $27,180,092
- Contributions
- $34,677,585
- Grants paid
- $18,049,864
-
2023
- Revenue
- $22,749,028
- Expenses
- $30,962,554
- Contributions
- $21,134,092
- Grants paid
- $21,875,654
-
2022
- Revenue
- $18,297,575
- Expenses
- $28,681,699
- Contributions
- $19,131,206
- Grants paid
- $19,379,059
The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.
Other returns filed
-
2021 · 990
- Revenue
- $30,446,505
- Expenses
- $33,834,657
- Assets (EOY)
- $78,505,397
-
2020 · 990
- Revenue
- $24,467,833
- Expenses
- $21,726,029
- Assets (EOY)
- $96,561,632
-
2019 · 990
- Revenue
- $14,966,634
- Expenses
- $24,862,781
- Assets (EOY)
- $90,551,380
-
2018 · 990
- Revenue
- $29,500,163
- Expenses
- $29,535,726
- Assets (EOY)
- $99,323,748
-
2017 · 990
- Revenue
- $44,255,198
- Expenses
- $23,085,254
- Assets (EOY)
- $105,061,017
-
2016 · 990
- Revenue
- $43,523,969
- Expenses
- $22,729,922
- Assets (EOY)
- $80,072,447
-
2015 · 990
- Revenue
- $25,683,089
- Expenses
- $22,172,709
- Assets (EOY)
- $58,218,034
-
2014 · 990
- Revenue
- $23,347,316
- Expenses
- $16,238,426
- Assets (EOY)
- $56,098,889
-
2013 · 990
- Revenue
- $17,350,714
- Expenses
- $14,531,745
- Assets (EOY)
- $49,039,952
-
2012 · 990
- Revenue
- not reported
- Expenses
- $10,425,689
- Assets (EOY)
- $40,586,902
Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.
Grants made
-
$8,784,577
2023 PANCREATIC CANCER RESEARCH
-
$6,410,909
2024 PANCREATIC CANCER RESEARCH
-
$5,726,518
2022 PANCREATIC CANCER RESEARCH
-
$2,823,857
2023 PANCREATIC CANCER RESEARCH
-
$2,472,272
2022 PANCREATIC CANCER RESEARCH
-
$2,161,911
2022 PANCREATIC CANCER RESEARCH
-
$1,987,065
2023 PANCREATIC CANCER RESEARCH
-
$1,937,943
2024 PANCREATIC CANCER RESEARCH
-
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
$1,915,072
2023 PANCREATIC CANCER RESEARCH
-
AMERICAN ASSOCIATION FOR CANCER RESEARCH
$1,593,497
2024 PANCREATIC CANCER RESEARCH
The 10 largest by cash amount. The API serves every itemized grant.
Grants received
-
$988,999
2022 TO SUPPORT MEDICAL RESEARCH
-
2024 For grant recipient's exempt purposes
-
$500,000
2024 To Be Used at the Organization's Discretion
-
2022 For grant recipient's exempt purposes
-
2023 For grant recipient's exempt purposes
-
DONOR ADVISED CHARITABLE GIVING
$348,639
2023 HUMAN SERVICES
-
DONOR ADVISED CHARITABLE GIVING
$336,475
2024 HUMAN SERVICES
-
$267,750
2023 HEALTH
-
2023 GENERAL SUPPORT
-
2022 GENERAL SUPPORT
The 10 largest by cash amount. The API serves every itemized grant.
Other IRS files
Auto-Revocation List
Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.
Publication 78
Listed as of 13 October 2026, under deductibility PC.
These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.
What this page reflects
The registration facts above come from the IRS Business Master File published 13 October 2026 and read 26 October 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.